Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56dim natural killer cells
- 31 May 2008
- journal article
- Published by Elsevier BV in Molecular Immunology
- Vol. 45 (9), 2559-2569
- https://doi.org/10.1016/j.molimm.2008.01.001
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2– versus IL-15–activated NK cellsBlood, 2007
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine designNature Reviews Immunology, 2006
- A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer CellsImmunity, 2005
- Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory PotentialThe Journal of Experimental Medicine, 2003
- In vivo evidence for a dependence on interleukin 15 for survival of natural killer cellsBlood, 2002
- Overexpression of interleukin‐15 prevents the development of murine retrovirus‐induced acquired immunodeficiency syndromeThe FASEB Journal, 2002
- Peripheral Deletion of Autoreactive CD8 T Cells by Cross Presentation of Self-Antigen Occurs by a Bcl-2–inhibitable Pathway Mediated by BimThe Journal of Experimental Medicine, 2002
- Interleukin-15 Prevents Mouse Mast Cell Apoptosis through STAT6-mediated Bcl-xL ExpressionPublished by Elsevier BV ,2001
- BCL-2 FAMILY: Regulators of Cell DeathAnnual Review of Immunology, 1998
- Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient MiceCell, 1997